These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1595713)

  • 1. Can we regulate the quality of care?: the case of dialysis in Connecticut.
    Brown E; Smith JD; Sindelar J
    Am J Kidney Dis; 1992 Jun; 19(6):609-13. PubMed ID: 1595713
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis in Connecticut.
    Rettig RA
    Am J Kidney Dis; 1992 Jun; 19(6):614-6. PubMed ID: 1472189
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule.
    Fed Regist; 1997 Aug; 62(158):43657-74. PubMed ID: 10169837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESRD health care screens spell increasing regulation for dialysis facilities.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1991 Feb; 5(2):20-1, 30. PubMed ID: 1997871
    [No Abstract]   [Full Text] [Related]  

  • 5. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If daily dialysis is the answer, what is the question?
    Rettig RA
    Am J Kidney Dis; 2001 Apr; 37(4):862-5. PubMed ID: 11273889
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 9. The Medicare end-stage renal disease program. A report from the Institute of Medicine.
    Levinsky NG; Rettig RA
    N Engl J Med; 1991 Apr; 324(16):1143-8. PubMed ID: 2008193
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for daily dialysis: its impact on costs and quality of life.
    Mohr PE; Neumann PJ; Franco SJ; Marainen J; Lockridge R; Ting G
    Am J Kidney Dis; 2001 Apr; 37(4):777-89. PubMed ID: 11273878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selected cost-containment efforts: 1971-1993.
    Gold M; Chu K; Felt S; Harrington M; Lake T
    Health Care Financ Rev; 1993; 14(3):183-225. PubMed ID: 10130576
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The best outcomes: are they in for-profit or not-for-profit units?
    Sadler JH
    Nephrol News Issues; 2000 Mar; 14(4):46-8. PubMed ID: 11075102
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Nov; 77(218):67450-531. PubMed ID: 23139948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home vs. in-center dialysis: reassessing the burdens.
    Schatell D
    Nephrol Nurs J; 2005; 32(3):347. PubMed ID: 16035476
    [No Abstract]   [Full Text] [Related]  

  • 17. New Medicare payment rules encourage home dialysis, but how to get patients started?
    Neumann ME
    Nephrol News Issues; 2011 Nov; 25(12):17. PubMed ID: 22204163
    [No Abstract]   [Full Text] [Related]  

  • 18. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
    Kanter A; Nidetz M
    Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
    [No Abstract]   [Full Text] [Related]  

  • 20. The due diligence on the ESRD payment cut.
    Neumann ME
    Nephrol News Issues; 2013 Oct; 27(11):8. PubMed ID: 24288801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.